Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$69.28
pos +1.11
+1.63%
Today's Range: 68.34 - 69.89 | GILD Avg Daily Volume: 15,558,300
Last Update: 04/16/14 - 4:00 PM EDT
Volume: 17,198,720
YTD Performance: -9.23%
Open: $69.32
Previous Close: $68.17
52 Week Range: $46.70 - $84.88
Oustanding Shares: 1,538,252,914
Market Cap: 102,713,229,521
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 17 16 16
Moderate Buy 2 2 2 2
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.21 1.20 1.21 1.30
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 42.97
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
42.97 36.80 28.47
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-9.38% 34.51% 226.95%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 121.60 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.75 $0.95 $3.92 $6.97
Number of Analysts 3 3 3 2
High Estimate $0.92 $1.33 $5.19 $8.83
Low Estimate $0.64 $0.71 $2.95 $5.12
Prior Year $0.45 $0.48 $1.92 $3.92
Growth Rate (Year over Year) 67.41% 98.61% 103.99% 78.09%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Algos think faster and react faster than humans can.
Let's categorize things in this vicious rotation.
Do you think I'm looking at yesterday's bloodbath as a buying opportunity?

Fitz Bits: The Biotech Wreck Real Money Pro($)

These stocks are broken -- and you can't un-break them

Fitz Bits: The Biotech Wreck Real Money Pro($)

These stocks are broken -- and you can't un-break them
Money managers need to be fashionable, and your advantage is that you don't.

Selectively Buying on Dips Real Money Pro($)

How well an investor masters this technique will determine performance this year.
These fanciful folks, it seems, just want to make themselves feel better about missing last year's 'phony' rally.
These shifts are just a function of institutional money management.

Columnist Conversations

Market posts the third day of solid gains in a row. Will see if we can make it four a row before the long hol...
With the averages now flying upwards, with everyone scrambling to buy, it is startling to remember how palpabl...
Inability of Bank of America (BAC) to claw its way above 16.30-.40 resistance will increase the likelihood tha...
The Fed works for the government. The Federal government owes over $16 trillion. The Fed will likley never rai...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.